ES423532A1 - 3-halo cephalosporins - Google Patents

3-halo cephalosporins

Info

Publication number
ES423532A1
ES423532A1 ES423532A ES423532A ES423532A1 ES 423532 A1 ES423532 A1 ES 423532A1 ES 423532 A ES423532 A ES 423532A ES 423532 A ES423532 A ES 423532A ES 423532 A1 ES423532 A1 ES 423532A1
Authority
ES
Spain
Prior art keywords
formula
group
see formula
hydrogen
see
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES423532A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of ES423532A1 publication Critical patent/ES423532A1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02Preparation
    • C07D501/04Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/59Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3 with hetero atoms directly attached in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A procedure for the preparation of 3-halocephalosporins of the formula: ** (See formula) ** where R is hydrogen or an acyl group of the formula ** (See formula) ** where R'is C1-C6 alkyl, C1-C3 haloalkyl cyano C1-C3 alkyl, phenyl, methylphenyl, hydroxyphenyl, halophenyl, nitrophenyl, aminophenyl, methoxyphenyl, 5-amino-5-carboxybutyl or a 5-amino-5-substituted ester group -carboxybutyl of formula: ** (See formula) ** where A is diphenylmethyl, p-nitrophenyl, p-methoxybenzyl, benzyl, tert-butyl or 2,2,2-trichlorethyl and A'is C2-C4 alkanoyl, C2-C4 haloalkanoyl, benzoyl, halobenzoyl, 2,4-dinitrophenyl or phthaloyl; or R'is a group of formula ** (See formula) ** where a and a'are independently hydrogen, C1-C4 lower alkyl, halogen lower alkoxy, hydroxy, nitro, amino or carboxy; Z is oxygen or sulfur; and m is 0 or 1; or R'is a group of formula ** (See formula) ** where P is 2-thienyl, 3-thienyl, phenyl, or a substituted phenyl group of the formula ** (See formula) ** where a and a'are defined above, Q is hydroxy, formyloxy, acetoxy, carboxy, or sulfo; or R'is a group of formula ** (See formula) ** where P has the meaning given above and Y is hydrogen, methyl or acetyl; or R'is a group of formula R'' - CH2- where R'' is 2-thienyl, 3-thienyl, 2-furyl, 2-oxazyl, 2-thiazyl or 1-tetrazyl; or R'is a group of formula where a, a', Z and m have the previously defined meaning; R1 is hydrogen, benzyl, p-methoxybenzyl, p-nitrobenzyl, diphenylmethyl, 2,2,2-trichlorethyl, tert-butyl or a pharmaceutically acceptable ester of the formula: ** (See formula) ** and X is chlorine or bromine; and when R1 is hydrogen, its pharmaceutically acceptable and non-toxic salts; whose procedure is characterized by reacting a compound of formula: ** (See formula) ** where R'is the one defined above and R2 is a forming group of a protective ester of carboxylic acid, a) with a halogenating agent in a solvent capable of forming an iminium halide, optionally followed by b) cleavage of the 7-acylamido side chain and optionally reacylation of the thus obtained 7-amino-3-halocephalosporin compound and c) if desired, remove the carboxylic acid protecting ester forming group to give the corresponding acid. (Machine-translation by Google Translate, not legally binding)
ES423532A 1973-02-23 1974-02-22 3-halo cephalosporins Expired ES423532A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33541473A 1973-02-23 1973-02-23

Publications (1)

Publication Number Publication Date
ES423532A1 true ES423532A1 (en) 1976-06-01

Family

ID=23311677

Family Applications (1)

Application Number Title Priority Date Filing Date
ES423532A Expired ES423532A1 (en) 1973-02-23 1974-02-22 3-halo cephalosporins

Country Status (34)

Country Link
JP (4) JPS612677B2 (en)
AR (3) AR208068A1 (en)
AT (1) AT333952B (en)
BE (1) BE811494A (en)
BG (1) BG22404A3 (en)
BR (1) BR7401385D0 (en)
CA (1) CA1032532A (en)
CH (1) CH594686A5 (en)
CS (1) CS189625B2 (en)
CY (1) CY1042A (en)
DD (1) DD110277A5 (en)
DE (1) DE2408686C2 (en)
ES (1) ES423532A1 (en)
FI (1) FI63240C (en)
FR (1) FR2218878B1 (en)
GB (1) GB1458293A (en)
GT (1) GT197432132A (en)
HK (1) HK19980A (en)
HU (1) HU167749B (en)
IE (1) IE38916B1 (en)
IL (1) IL44263A (en)
KE (1) KE3026A (en)
MW (1) MW574A1 (en)
MY (1) MY8100023A (en)
NL (1) NL181010C (en)
NO (2) NO148376C (en)
OA (1) OA04688A (en)
PH (1) PH14014A (en)
PL (1) PL88714B1 (en)
RO (1) RO64595A (en)
SE (1) SE411211B (en)
YU (2) YU36971B (en)
ZA (1) ZA741190B (en)
ZM (1) ZM3674A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT342197B (en) * 1975-02-20 1978-03-28 Ciba Geigy Ag NEW PROCESS FOR PRODUCING 3-CEPHEM CONNECTIONS
CH622802A5 (en) * 1975-08-20 1981-04-30 Ciba Geigy Ag
IE45158B1 (en) * 1976-08-16 1982-06-30 Lilly Co Eli 3-chloro-cephem synthesis
PH17188A (en) * 1977-03-14 1984-06-14 Fujisawa Pharmaceutical Co New cephem and cepham compounds and their pharmaceutical compositions and method of use
JPS62112053U (en) * 1985-12-27 1987-07-16
JPH0676861B2 (en) * 1988-05-24 1994-09-28 リンナイ株式会社 Control device for hot air heater
IT1255458B (en) * 1992-05-11 1995-11-02 Col Marco Da PROCEDURE FOR THE PREPARATION OF HALOGENATED BETA-LACTAMIC DERIVATIVES

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2143211B1 (en) * 1971-06-24 1975-10-31 Fujisawa Pharmaceutical Co

Also Published As

Publication number Publication date
BE811494A (en) 1974-08-22
PH14014A (en) 1980-12-08
CY1042A (en) 1980-08-01
IL44263A0 (en) 1974-05-16
YU46374A (en) 1982-06-18
RO64595A (en) 1981-01-30
BG22404A3 (en) 1977-02-20
GB1458293A (en) 1976-12-15
AU6591574A (en) 1975-08-28
AT333952B (en) 1976-12-27
SE411211B (en) 1979-12-10
NO740607L (en) 1974-08-26
CA1032532A (en) 1978-06-06
NL7402486A (en) 1974-08-27
PL88714B1 (en) 1976-09-30
FI63240B (en) 1983-01-31
JPS612677B2 (en) 1986-01-27
OA04688A (en) 1980-07-31
AR201709A1 (en) 1975-04-08
NO148376B (en) 1983-06-20
NL181010B (en) 1987-01-02
AR200908A1 (en) 1974-12-27
HU167749B (en) 1975-12-25
GT197432132A (en) 1975-08-16
JPS49116095A (en) 1974-11-06
JPS56138193A (en) 1981-10-28
HK19980A (en) 1980-04-25
JPS613357B2 (en) 1986-01-31
IE38916L (en) 1974-08-23
NO792609L (en) 1974-08-26
MW574A1 (en) 1975-05-13
ZA741190B (en) 1975-09-24
CS189625B2 (en) 1979-04-30
NL181010C (en) 1987-06-01
ATA142474A (en) 1976-04-15
JPS613358B2 (en) 1986-01-31
JPS56138194A (en) 1981-10-28
NO148376C (en) 1983-09-28
JPS56138195A (en) 1981-10-28
ZM3674A1 (en) 1975-11-21
CH594686A5 (en) 1978-01-31
FR2218878A1 (en) 1974-09-20
FI63240C (en) 1983-05-10
YU37347B (en) 1984-08-31
YU99880A (en) 1983-04-27
AR208068A1 (en) 1976-11-30
IL44263A (en) 1977-10-31
YU36971B (en) 1984-08-31
DE2408686A1 (en) 1974-09-05
KE3026A (en) 1980-03-14
IE38916B1 (en) 1978-06-21
DE2408686C2 (en) 1986-08-28
BR7401385D0 (en) 1974-11-05
JPS613356B2 (en) 1986-01-31
FR2218878B1 (en) 1977-03-11
DD110277A5 (en) 1974-12-12
MY8100023A (en) 1981-12-31

Similar Documents

Publication Publication Date Title
ES378765A1 (en) 3 7-(ring-substituted) cephalosporin compounds
GB1526978A (en) 3-thiosubstituted cephalosporin antibiotics
ES423532A1 (en) 3-halo cephalosporins
GB1507185A (en) Brominated 1-oxapenicillins
ES423531A1 (en) Alpha-aminoacyl-3-halo-cephalosporins
FI74967B (en) NYTT FOERFARANDE FOER FRAMSTAELLNING AV 7- AMINO-3-SUBSTITUERAD-TIOMETYL- 3-CEFEM-4-CARBOXYLSYROR.
US4115643A (en) Process for 3-chloro cephalosporins
ES393681A1 (en) 3-formyl cephalosporin sulfoxides
GB1053085A (en)
GB1462944A (en) Process for preparing cephalosporins
GB1454399A (en) Alphaaminoacyl cephalosporin ethers
SE7713901L (en) TIOOXIMCEPHALOSPORIN AND PENICILLIN DERIVATIVES
GB1457668A (en) Cephalo
ES8607960A1 (en) Aroyl benzofuran and benzothiophene acetic and propionic acids processes for their production and pharmaceutical compositions containing them.
GB1497039A (en) Penicillins and cephalosporins
IL41310A (en) The preparation of 3-carbamoyloxymethyl cephalosphorins
ES454668A1 (en) Bis-homophthalimides and salts thereof
GB1412856A (en) Process for preparing desacetoxycephalosporins and intermediates
GB1530157A (en) 3-(substituted)cephems
GB1505848A (en) 3,4-dicarboxycephalosporins and derivatives
SE7512818L (en) PROCEDURE FOR PREPARING DELTA? 723-CEPHALOSPORIN ASSOCIATIONS
GB1513280A (en) Therapeutic pyrazole derivatives
PL88471B1 (en)
IE38194L (en) 7-amino-7-alkoxycephalosporins
ES439989A1 (en) A procedure for the preparation of cefalosporine compounds. (Machine-translation by Google Translate, not legally binding)